I had a similar price estimation. A lower price for those who had DFU that didn't heal in 3 months but could order the patches and apply them at home and a higher price for those admitted to hospital, with varying differences in patch sizes, cell dosage and frequency the patches are applied.
Very interesting considering Diabetic wounds are some of the most difficult to heal, so DFU should just be a starting point if the results are good. Shouldn't be particularly difficult to get approval considering the cells are fixed in the scaffold and applied topically, unlike the hoops CYP will have to jump through if Cymerus were administered intravenously.
Wound healing in the battlefield should also be something CYP may want to take a look at.
CYP Price at posting:
36.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)